Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial. Golan Y, Campos JAS, Woolson R, Cilla D, et al. Clin Infect Dis 2022 Sep 6. pii: 6692456. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Golan Y, Campos JAS, Woolson R, Cilla D, et al. Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial. Clin Infect Dis 2022 Sep 6. pii: 6692456. doi: 10.1093.
PMID: 36065065